HCA HCA HEALTHCARE INC

2026Q1 · CUSIP 40412C101 · Sector: Healthcare & Biotech

Cooling · Breadth rolling over

Holders

1,404

Δ holders QoQ

+14

Breadth percentile

Top 22%

Whale holders

320

Δ whales

-5

Inst. holding value

$60.5B

New positions

149

Closed positions

135

Price momentum (1Q)

-20.8%

Put / Call

29/28

Breadth history (34 quarters)

Past Lit Events & Aftermath 22 lit events

Period	Percentile	Next-1Q return	Next-2Q return
2025Q4	Top 3%	-20.8%	—
2025Q3	Top 6%	+11.0%	-16.6%
2025Q2	Top 15%	+20.3%	+36.4%
2025Q1	Top 3%	+4.3%	+23.8%
2024Q3	Top 5%	-5.6%	+12.6%
2024Q2	Top 7%	-7.4%	-13.9%
2024Q1	Top 2%	+16.1%	+6.6%
2023Q4	Top 8%	+4.9%	+21.8%
2023Q2	Top 3%	-10.8%	+15.7%
2023Q1	Top 12%	-3.4%	-12.1%
2022Q4	Top 3%	+6.4%	+2.7%
2022Q1	Top 6%	-2.9%	+6.7%
2021Q4	Top 7%	-17.8%	-14.2%
2021Q3	Top 1%	+4.5%	-14.1%
2021Q2	Top 5%	-0.2%	-4.1%
2020Q4	Top 10%	+20.7%	+42.2%
2020Q3	Top 6%	+15.2%	+34.7%
2019Q4	Top 13%	-28.5%	-9.1%
2019Q3	Top 19%	+8.6%	-21.7%
2018Q4	Top 4%	-12.2%	-12.7%
2018Q2	Top 6%	+8.7%	+11.9%
2018Q1	Top 1%	+25.6%	+36.5%

Show all 22 events

Options Sentiment

Put holders

QoQ: 0

Call holders

QoQ: +1

See methodology →

Fundamentals

PE (TTM)

12.8

EPS (TTM)

$29.03

EPS YoY

+28.9%

Revenue (TTM)

$76.4B

Revenue YoY

+6.7%

Net margin

8.9%

ROE

—

Debt ratio

110.3%

FCF (TTM)

$7.9B

Dividend (TTM)

$2.94

Quarterly Revenue & EPS (4Y)

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)

Get the next update

2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.